CSF2 and neoplasm: OVs such as the modified vaccinia virus strain JX-594 (Pexa-Vec) have been developed to express granulocyte-macrophage colony-stimulating factor (GM-CSF), providing a dual therapeutic mechanism through direct tumor cell destruction and stimulation of the immune system [63,64].